Meet Kenneth
Biotech Investor/Rejuvenation Biohacker
Kenneth is a software developer, mathematician, biohacker, and a seed investor in biotech companies addressing age-related infirmities, with deep knowledge of the aging disease therapeutic and business landscape.His mission is to challenge the conventional approach to lifespan and healthspan by emphasizing the transformative power of rejuvenation as the ultimate goal for achieving longevity, possibly even immortality.
Driven by his commitment to pushing boundaries and dedication to cutting-edge advancements, he has made significant contributions to the field of rejuvenation by undergoing multiple rounds of gene therapy in Central America.
Kenneth born in Scotland, grew up in Canada and Germany where he developed an interest in math at a young age.
He studied engineering, physics, and mathematics at Carleton University in Ottawa, Canada. He earned his master’s degree in Math while serving in the Royal Canadian Air Force as an aeronautical engineer.
He did PhD work in geometry and also worked as an economist in the Canadian Department of Manpower and Immigration. Kenneth has made numerous innovative contributions to software development.
He played a pivotal role in developing groundbreaking software that revolutionized the softdrink industry. Kenneth also managed software development, in India, for Flycode Inc., which served as an inspiration for YouTube’s evolution.
Furthermore, he has extensive experience creating IT products like file transfer protocol and relational database management systems. With his dedication to creating groundbreaking solutions, Kenneth continues to push the boundaries by tackling rejuvenation. He is the co-founder and the managing investor for VivaSparkle’s Human Longevity and Rejuvenation syndicate on AngelList. Viva Sparkle is a firm that aims to extend the human lifespan and improve the quality of life via rejuvenation and investment in promising biotech firms. He is also committed to Riley Farm Development, his real estate development and nature conservation project in Saratoga Springs, New York, which aims to protect natural habitats while promoting sustainable development.
The Present
He sits on the Advisory Board of several companies, including Lento Bio, a company with two main long-term goals: making a successful therapeutic asset targeting underlying damage in presbyopia and furthering the development of therapeutics for aging diseases which target biomolecular damage; and Global Ideas Development, which develops marketing frameworks to support life science companies in fueling more impactful innovation.